Longview
Longview

Valuation Engine

Level-3 values are only as good as their documented assumptions — so every mark carries its methodology with it.

methodology v6.2

Don't call every number 'value'

Illustrated on LS-10482 — five numbers, five meanings

Cost basis
$510,000

What you actually have invested — acquisition plus premiums paid.

Current fair value / NAV mark
$644,000

Accounting valuation using the fund's stated methodology. Level-3: important inputs are not observable in a liquid market.

Estimated tertiary market value
$592,000

What market evidence suggests the policy could potentially sell for today.

Modeled hold-to-maturity value
$718,000

Probability-weighted model across the survival curve.

Death benefit
$2,000,000

The contractual policy benefit. Not a valuation — a ceiling.

This transparency is the selling point — investors trust numbers they can tell apart.

Assumptions — preserved beside every mark

When methodology changes, history keeps its original inputs

Methodology versionv6.2 — effective Jun 30, 2026
Mortality table2015 VBT, provider-adjusted
LE inputsTwo providers, blended; variance logged
Discount rate14.0% (cohort-based)
Premium scheduleCarrier illustration, verified in force
Prior methodologyv6.1 archived with every historical mark

Recent mark updates

Every change: old value, new value, and why

LS-10914Sep 2026
$996,000 → $1,010,000
New LE report (−2 mo); discount unchanged
LS-10482Sep 2026
$638,000 → $644,000
Premium paid; time-decay accretion
LS-10645Aug 2026
$1,340,000 → $1,290,000
LE extension +14 mo — mark reduced